Terrana Biosciences

Terrana Biosciences, founded in 2021 and headquartered in Cambridge, US, specializes in RNA-based innovations for agriculture.Terrana Biosciences specializes in innovative RNA-based plant health solutions designed to address various challenges in agriculture. Its flagship product offerings leverage a comprehensive RNA platform that integrates nature’s intelligence with machine learning to facilitate plant health from seed to stem. The company's solutions are aimed at tackling issues such as disease prevention, pest management, rapid adaptation to climatic changes, and enhancing soil health. Terrana's product line is targeted toward agricultural stakeholders, including farmers, agronomists, and agricultural research institutions, facilitating improved crop yields and resilience.Terrana Biosciences generates revenue through business-to-business transactions, primarily by collaborating with agricultural organizations and research institutions. These partnerships involve providing tailored RNA-based solutions that can be integrated into existing agricultural practices. The company structures its transactions through licensing agreements or direct sales to clients, allowing for customization based on specific regional agricultural needs. While specific pricing details are not disclosed, the revenue model involves multi-year contracts providing ongoing support and product access, ensuring clients can effectively utilize Terrana’s technologies throughout the growing season. Furthermore, Terrana aims to expand its market presence in North America, Europe, and Asia by introducing new products designed to meet the evolving demands of sustainable agriculture.

1. Series B

   Jul 1, 2025

   Amount

   $50M

   Investors

   Locked